Disease Control

Strain-Specific Vaccines Could Stem Meningitis Epidemics

Published in Vaccine Weekly, May 10th, 1999

Strain-specific meningococcal vaccines could be effectively deployed in epidemic situations, a study led by U.S. Centers for Disease Control and Prevention (CDC) researchers suggests.

The study, conducted in 1994 during a serogroup B meningococcal disease epidemic in Santiago, Chile, tested two similar vaccines made in Cuba and Norway. Both vaccines were derived from the outer membrane protein (OMP) of Neisseria meningitidis. The vaccines were made from bacterial strains that did not exactly match the epidemic strain.

Children and adults who received either of the vaccines were more likely than placebo recipients to develop immune responses...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Vaccine Weekly

Source: Vaccine Weekly (1999-05-10)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry